October 10, 2025Leukemia & lymphoma/Leukemia and lymphoma

Soluble BCMA as a biomarker reflecting tumor volume and treatment response in Waldenström macroglobulinemia

View Full Paper

Ask AI

Bookmark

Soluble BCMA levels in symptomatic wm patients were significantly higher than in healthy controls, suggesting its role as a biomarker.
The median soluble BCMA level in patients was 100 ng/mL compared to 41.4 ng/mL in controls, showing strong statistical significance (p < 0.001).
There's a robust correlation between soluble BCMA and bone marrow cd20+ cell counts, highlighting its potential in assessing tumor burden.
Furthermore, soluble BCMA levels change in tandem with serum IgM levels, indicating its reliability in predicting treatment efficacy.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Observational analysis reveals soluble BCMA correlates with tumor volume and treatment response in waldenström macroglobulinemia patients, indicating clinical utility.

Cite This Study

Oura et al. (2025) studied this question.

synapsesocial.com/papers/68e9435d2d5336d28fb289f0 https://doi.org/10.1080/10428194.2025.2569759

View Full Paper

Ask AI

Bookmark

Implication

Observational analysis reveals soluble BCMA correlates with tumor volume and treatment response in waldenström macroglobulinemia patients, indicating clinical utility.

Soluble BCMA as a biomarker reflecting tumor volume and treatment response in Waldenström macroglobulinemia

Key Points

Discussion

Implication

Cite This Study

Soluble BCMA as a biomarker reflecting tumor volume and treatment response in Waldenström macroglobulinemia

Key Points

Discussion

Implication

Cite This Study